These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

674 related items for PubMed ID: 51889

  • 1. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E, Bonavida B.
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [Abstract] [Full Text] [Related]

  • 2. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F, Jongeneel V, Cerottini JC, Brunner KT.
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [Abstract] [Full Text] [Related]

  • 3. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR.
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CD3+ T cells in severe combined immunodeficiency (scid) mice. IV. Graft-vs.-host resistance of H-2d scid mice to intravenous injection of allogeneic H-2b (C57BL/6) spleen cells.
    Claesson MH, Rudolphi A, Tscherning T, Reimann J.
    Eur J Immunol; 1991 Sep; 21(9):2057-62. PubMed ID: 1832384
    [Abstract] [Full Text] [Related]

  • 9. Alloimmune cytotoxic T cells: Evidence that they recognize serologically defined antigens and bear clonally restricted receptors.
    Bevan MJ.
    J Immunol; 1975 Jan; 114(1 Pt 2):316-9. PubMed ID: 123256
    [Abstract] [Full Text] [Related]

  • 10. Continuously proliferating T killer cells specific for H-2b targets: selection and characterization.
    Dennert G, De Rose M.
    J Immunol; 1976 Jun; 116(6):1601-6. PubMed ID: 58039
    [Abstract] [Full Text] [Related]

  • 11. Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response.
    Ting CC, Kirchner H, Rodrigues D, Park JY, Herberman RB.
    J Immunol; 1976 Jan; 116(1):244-52. PubMed ID: 54388
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S, Yamamoto H, Fujii Y, Arai S.
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [Abstract] [Full Text] [Related]

  • 13. The importance of serologically detectable histocompatibility antigens in the induction and effector step of cell-mediated lysis.
    Dennert G, Hyman R.
    Eur J Immunol; 1977 May; 7(5):251-7. PubMed ID: 141372
    [Abstract] [Full Text] [Related]

  • 14. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J, Bonavida B.
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Studies on the induction and expression of T cell-mediated immunity. 3. Amplification by papain of the generation of cytotoxic lymphocytes to allogeneic cells.
    Kedar E, Bonavida B.
    J Immunol; 1974 Oct; 113(4):1386-9. PubMed ID: 4153487
    [No Abstract] [Full Text] [Related]

  • 18. In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens.
    Burton RC, Chism SE, Warner NL.
    J Immunol; 1977 Mar; 118(3):971-80. PubMed ID: 300394
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
    Toffaletti DL, Darrow TL, Scott DW.
    J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.